🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In addition to the blood pressure lowering effects of aliskiren, it may hav...
Status
Completed
Location
Novartis Investigator Site
Start Date
2009-05
Trial ID
NCT00923156
Treatments Being Tested
NephroNet proposes to examine whether combining Spironolactone with maximal...
Status
Unknown
Location
Georgia Nephrology Research Institute
Start Date
2018-10-01
Trial ID
NCT03502031
The main study will be a two arm 10-month, cross-over randomized controlled...
Status
Completed
Location
University of California San Francisco
Start Date
2022-02-02
Trial ID
NCT05159999
Treatments Being Tested
The efficacy of interruption of the renin-angiotensin-aldosterone system (R...
Status
Completed
Location
University of Colorado Health Sciences Center
Start Date
2006-01
Trial ID
NCT00283686
Treatments Being Tested
The Taiwan Consortium of Acute Kidney Injury and Renal Diseases (TCTC) is l...
Status
Unknown
Location
Kaohsiung Medical University Hospital
Start Date
2019-02-15
Trial ID
NCT05064904
Treatments Being Tested
In Germany nearly half of the population present elevated values of blood p...
Status
Completed
Location
Multiple Locations
Start Date
2008-10
Trial ID
NCT01454583
Treatments Being Tested
The primary objective of this study is to demonstrate that in patients with...
Status
Completed
Location
Ziekenhuis Oost Limburg
Start Date
2014-07
Trial ID
NCT02200822
Treatments Being Tested
Blockage of renin-angiotensin-aldosterone system (RAAS) by angiotensin conv...
Status
Completed
Location
Ainshams University
Start Date
2021-06-15
Trial ID
NCT05418361
Treatments Being Tested
Pediatric chronic kidney disease (CKD) results from health conditions that ...
Status
Completed
Location
Children's Hospital of Philadelphia
Start Date
2023-09-22
Trial ID
NCT05169411
Treatments Being Tested
Antiangiogenic therapies like bevacizumab, have notably improved cancer tre...
Status
Unknown
Location
Institut Curie
Start Date
2024-05-20
Trial ID
NCT06515678